CN104095783A - 一种中药消炎拔痘美容霜及其制备方法 - Google Patents
一种中药消炎拔痘美容霜及其制备方法 Download PDFInfo
- Publication number
- CN104095783A CN104095783A CN201410292438.1A CN201410292438A CN104095783A CN 104095783 A CN104095783 A CN 104095783A CN 201410292438 A CN201410292438 A CN 201410292438A CN 104095783 A CN104095783 A CN 104095783A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- acne
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 63
- 206010000496 acne Diseases 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 19
- 239000006071 cream Substances 0.000 title claims abstract description 17
- 230000003796 beauty Effects 0.000 title claims abstract 9
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- 230000001741 anti-phlogistic effect Effects 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 41
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims abstract description 21
- 239000000284 extract Substances 0.000 claims abstract description 21
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 19
- 235000011187 glycerol Nutrition 0.000 claims abstract description 15
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims abstract description 15
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000021355 Stearic acid Nutrition 0.000 claims abstract description 13
- 230000003255 anti-acne Effects 0.000 claims abstract description 13
- 238000000605 extraction Methods 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 13
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims abstract description 13
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000008117 stearic acid Substances 0.000 claims abstract description 13
- 244000183278 Nephelium litchi Species 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 241000723346 Cinnamomum camphora Species 0.000 claims abstract description 5
- 229960000846 camphor Drugs 0.000 claims abstract description 5
- 229930008380 camphor Natural products 0.000 claims abstract description 5
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims abstract description 5
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000015742 Nephelium litchi Nutrition 0.000 claims abstract 5
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims abstract 4
- 235000009496 Juglans regia Nutrition 0.000 claims abstract 4
- 240000000528 Ricinus communis Species 0.000 claims abstract 4
- 235000004443 Ricinus communis Nutrition 0.000 claims abstract 4
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims abstract 4
- 235000013871 bee wax Nutrition 0.000 claims abstract 4
- 239000012166 beeswax Substances 0.000 claims abstract 4
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims abstract 4
- 235000020234 walnut Nutrition 0.000 claims abstract 4
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims abstract 3
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims abstract 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims abstract 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims abstract 3
- 229960002216 methylparaben Drugs 0.000 claims abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 57
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 43
- 238000003756 stirring Methods 0.000 claims description 27
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 20
- 239000008367 deionised water Substances 0.000 claims description 15
- 229910021641 deionized water Inorganic materials 0.000 claims description 15
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 13
- 229920000053 polysorbate 80 Polymers 0.000 claims description 13
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 12
- -1 filter twice Substances 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 125000004494 ethyl ester group Chemical group 0.000 claims description 8
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- 241000758789 Juglans Species 0.000 claims description 4
- 239000002674 ointment Substances 0.000 claims description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 2
- 238000007796 conventional method Methods 0.000 claims description 2
- 239000004519 grease Substances 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 3
- 238000004042 decolorization Methods 0.000 claims 3
- 239000007864 aqueous solution Substances 0.000 claims 2
- 239000012141 concentrate Substances 0.000 claims 2
- 238000004945 emulsification Methods 0.000 claims 2
- 230000005484 gravity Effects 0.000 claims 1
- 238000010298 pulverizing process Methods 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 abstract description 7
- 230000003078 antioxidant effect Effects 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 4
- 230000035515 penetration Effects 0.000 abstract description 2
- 230000037394 skin elasticity Effects 0.000 abstract description 2
- 240000007049 Juglans regia Species 0.000 abstract 1
- 125000005456 glyceride group Chemical group 0.000 abstract 1
- 231100000344 non-irritating Toxicity 0.000 abstract 1
- 230000019612 pigmentation Effects 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 description 54
- 210000003491 skin Anatomy 0.000 description 37
- 241000700647 Variola virus Species 0.000 description 23
- 239000003921 oil Substances 0.000 description 22
- 230000000694 effects Effects 0.000 description 20
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 239000007766 cera flava Substances 0.000 description 16
- 230000001804 emulsifying effect Effects 0.000 description 16
- 229940025250 camphora Drugs 0.000 description 15
- 239000010238 camphora Substances 0.000 description 15
- 208000002193 Pain Diseases 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 239000002537 cosmetic Substances 0.000 description 10
- 230000036407 pain Effects 0.000 description 10
- 239000008278 cosmetic cream Substances 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 235000014593 oils and fats Nutrition 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 239000007908 nanoemulsion Substances 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 208000003351 Melanosis Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000011148 porous material Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 230000008034 disappearance Effects 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 238000000874 microwave-assisted extraction Methods 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 238000005352 clarification Methods 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 230000001815 facial effect Effects 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 241000186427 Cutibacterium acnes Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 210000002189 macula lutea Anatomy 0.000 description 3
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 235000019260 propionic acid Nutrition 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical group OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 241000256846 Apis cerana Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 244000293323 Cosmos caudatus Species 0.000 description 2
- 235000005956 Cosmos caudatus Nutrition 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010024229 Leprosy Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 240000003864 Ulex europaeus Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 235000009392 Vitis Nutrition 0.000 description 2
- 241000219095 Vitis Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000010612 desalination reaction Methods 0.000 description 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical class COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- WEFHSZAZNMEWKJ-KEDVMYETSA-N (6Z,8E)-undeca-6,8,10-trien-2-one (6E,8E)-undeca-6,8,10-trien-2-one (6Z,8E)-undeca-6,8,10-trien-3-one (6E,8E)-undeca-6,8,10-trien-3-one (6Z,8E)-undeca-6,8,10-trien-4-one (6E,8E)-undeca-6,8,10-trien-4-one Chemical compound CCCC(=O)C\C=C\C=C\C=C.CCCC(=O)C\C=C/C=C/C=C.CCC(=O)CC\C=C\C=C\C=C.CCC(=O)CC\C=C/C=C/C=C.CC(=O)CCC\C=C\C=C\C=C.CC(=O)CCC\C=C/C=C/C=C WEFHSZAZNMEWKJ-KEDVMYETSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000746375 Andrographis Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 206010055000 Bromhidrosis Diseases 0.000 description 1
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 1
- 241000219357 Cactaceae Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 240000005636 Dryobalanops aromatica Species 0.000 description 1
- 241000221079 Euphorbia <genus> Species 0.000 description 1
- 241000116713 Ferula gummosa Species 0.000 description 1
- 240000003537 Ficus benghalensis Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- 235000013757 Juglans Nutrition 0.000 description 1
- 208000002260 Keloid Diseases 0.000 description 1
- 206010023330 Keloid scar Diseases 0.000 description 1
- 241001362856 Lepisorus miyoshianus Species 0.000 description 1
- 229930194248 Licoflavone Natural products 0.000 description 1
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- 241000218998 Salicaceae Species 0.000 description 1
- 206010048810 Sebaceous hyperplasia Diseases 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 241001506047 Tremella Species 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 235000001667 Vitex agnus castus Nutrition 0.000 description 1
- 244000063464 Vitex agnus-castus Species 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000007765 cera alba Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000009347 chasteberry Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000007957 coemulsifier Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 239000008344 egg yolk phospholipid Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 239000004864 galbanum Substances 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 210000001117 keloid Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000037324 pain perception Effects 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical group CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000001835 salubrious effect Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 229910052613 tourmaline Inorganic materials 0.000 description 1
- 229940070527 tourmaline Drugs 0.000 description 1
- 239000011032 tourmaline Substances 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
一种中药消炎拔痘美容霜及其制备方法,由以下原料组分和重量份数制成:酸荔枝核3-3.5份,大风子仁0.6份,核桃仁0.6份,蓖麻子0.5-0.6份,樟脑0.6份,松香0.0375份,蜂蜡0.3份,硬脂酸0.45份,甘油0.37-0.38份,三乙醇胺0.075份,尼泊金甲酯和尼泊金乙酯各0.0037-0.0039份,自乳化单甘酯0.0375份,吐温-800.037-0.038份。本产品色泽自然,稳定性佳,质地细腻,易于涂展,不油腻并易于洗除,对皮肤无刺激性,释放性能好,药物对皮肤的穿透性能好,增加皮肤弹性,减轻色素沉着。本方法提取率高,能够有效提取中药中抗氧化成分,具有较好的经济效益和社会效益。
Description
技术领域
本发明属于中药剂和日用化工技术领域,涉及一种中药消炎拔痘美容霜及其制备方法。
背景技术
痘痘是很多人的心病,很多痘痘都是走了又来,无法根除。原因到底是什么呢?其实可能跟大家的生活习惯还有饮食习惯有关。西医认为痘痘一般是因为体内雄性激素分泌增多或相对增高,刺激皮脂腺增生肥大,分泌油脂量上升。另外痘痘的病因还与一些病原菌感染有关,已经证实的痘痘与丙酸痤疮棒状杆菌感染有关。这种棒状杆菌寄生于青春期的毛囊皮脂腺里,通过脂酶的催化作用,会水解产生甘油三脂和较多的游离脂肪酸,这些游离脂肪酸能使毛囊及毛囊周围发生非特异性炎症反应。中医学认为皮肤是五脏的“镜子”,皮肤表面的痘痘与人的五脏六腑关系密切,中医医学研究表明:痘痘虽然生长在皮肤表面,但与脏腑功能失调息息相关。引起痤疮的原因是:面鼻及胸背部属肺,本病常由肺经风热阻于肌肤所致;或因过食肥甘、油腻、辛辣食物,脾胃蕴热,湿热内生,熏蒸于面而成;或因青春之体,血气方刚,阳热上升,与风寒相搏,郁阻肌肤所致。中医学上认为痘痘的起因分多种情况:肾阴不足,肺热、胃热、血热经常导致痘痘产生,此外痰瘀互结,冲任不调等原因也会导致一些痘痘的出现,针对不同的“内因”要采取相应的调理办法,才能从根本上治愈。
随着人们生活水平的提高,现代人对于美的追求也越来越高,在人们追求绿色化妆品、回归自然的心理日益增强,天然活性化妆品顺应回归大自然的发展潮流和人们的消费心理。以无毒无副作用的天然产物为活性添加剂和化妆品原料的化妆用品成为精细化学品行业一大热点,安全、无副作用的美白产品应运而生,一些具有很好的美白效果的中草药目前越来越受到消费者的青昧,是化妆品“绿色”2l世纪的主题。目前,市面上祛痘的产品很多如:祛痘洗面奶、祛痘面膜、祛痘液,祛痘精油等等,也开发了中药消痘产品。
中国专利CN101229115B,一种祛痘祛斑美白的美容产品及其制备方法。其配方是由精制海狗油、白芷、归尾、白附子、黄芩、薏苡仁、黄柏、金银花、珍珠粉、川芎、丹参、防风、桃仁和甘油共同组成;中药制备流浸膏,成品并包装。
中国专利CN102178791B,排毒祛痘剂及其制备方法和使用方法。是以葡萄籽为主要原料配伍排毒祛痘剂的方法,将葡萄籽、干枸杞子、炙甘草粉以74.4%、24.8%、0.8%的重量比混合、粉碎、搅拌均匀。
中国专利CN1125644,治疗痤疮的药膏。是由下述重量配比的原料制成的药剂:珍珠粉1-15、银耳粉2-12、樟脑5-20、薄荷10-20、黄连1-5、大黄1-5、白矾1-4、硫磺粉0.2-2、麝香2-4、冰片0.2-1、地塞米松0.1-0.8、白凡士林20-50、乙醇0.3-1.5。
中国专利CN1299699,一种祛痘防病中药制剂。由30%-50%(以重量计,下同)的蜂蜜、15%的灵芝粉、15%-20%的丹参粉、10%-15%的生地粉、5%-10%的丹皮粉、5%-10%的蚤休混配成膏状。
中国专利CN101214199B,纳米活性祛痘化妆品组合物,该组合物包含:含有活性成分的纳米乳液,占组合物5-45wt%;活性成分的纳米乳液的组成为:a)活性成分,取自于维他命A脂肪酸酯、维他命C脂肪酸酯、维他命E脂肪酸酯、有机酸、抗炎剂、脂溶性防腐杀菌剂其中至少的一种,前述各成分及其在纳米乳液中含量分别为:维他命A脂肪酸酯选自于维他命A醋酸酯,其含量为0.1-2.0wt%;维他命C脂肪酸酯选自于L-抗坏血酸2-己基葵四酯或L-抗坏血酸四异棕榈酸酯,其含量为2-25wt%;维他命E脂肪酸酯选自a-生育酚三梨酸酯或a-生育酚醋酸酯,其含量为2-25wt%;有机酸选自苹果酸、柠檬酸、壬二酸或水杨酸,其含量为2-30wt%;脂溶性防腐杀菌剂选自于尼泊金丙酯、尼泊金丁酯或2,4,4-三氯-2-羟基二苯醚,其含量为1-10wt%;抗炎剂选自于甘草黄酮或a-红没药醇,其含量为0.5-30wt%;b)乳化剂,选自于氢化鸡蛋卵磷脂或氢化大豆卵磷脂,其在纳米乳液中含量为1-10wt%;c)油脂,选自于角鲨烷、棕榈酸异丙酯、肉豆蔻酸异丙酯、豆油其中的至少一种,其在纳米乳液中含量为2-15wt%;d)稳定剂,选自于丁基化羟基甲苯、丁基化羟基苯甲醚、丙基化没食子酸盐或a-生育酚其中至少的一种,其在纳米乳液中含量为0.01-0.1wt%;e)余量为去离子水;活性成分的纳米乳液采用以下方法制备:i在圆形长颈瓶中按配方中的比例依次加入活性成分、油脂、乳化剂和稳定剂;ii然后加入乙醇并摇晃溶解,之后,用旋转蒸发器将乙醇蒸发;iii按比例加入去离子水并震动搅拌直到形成均一的混合液,即初级乳液;iv将iii步骤制备的初级乳液导入高压均质器中,循环均质并获得所需的乳液粒径,均质时压力为500-1500巴,均质时间10-30分钟,温度30-40℃的恒温下进行,形成分布均一、稳定的粒径50纳米至500纳米的纳米乳液;II抗氧剂,选自于丁基化羟基甲苯、丁基化羟基苯甲醚、丙基化没食子酸盐或a-生育酚其中至少的一种,其含量占组合物的0.01-0.10wt%;III增稠剂,选自于汉生胶、羟乙基纤维素、羟丙基纤维素、酸性的羟基聚合物其中至少的一种,其含量占组合物的0.1-1.0wt%;IV其余为化妆品可接受的载体和去离子水。
中国专利CN102949322B,一种功效化妆品及其制备方法,其特征是以不同比例的茶树枝叶、马齿苋、罗汉果茎叶、木兰叶、穿心莲、黄柏为提取功效成分的植物原料;电气石为功效矿物原料;甘油为润湿剂;桃胶为助悬剂;鲸蜡硬脂基橄榄油酯和山梨醇橄榄油酯为辅助乳化剂;吐温-80和司盘-80为乳化剂;经水蒸汽蒸馏、胶体磨研磨和高压均质机均质得细腻乳液,该乳液祛痘不留痕,兼有去皱、祛斑、润肤美白之功效。
中国专利CN102670469B,一种祛痘化妆品及其制备方法,按重量百分比计,由以下组分组成:A组分:去离子水64-78%,透明质酸钠0.01-0.2%,1,3-丁二醇2-10%,丙烯酰二甲基牛磺酸铵/VP共聚物0.5-1%,丙烯酸(酯)类/乙烯醇异癸酸酯交联聚合物钠0.15-0.5%,三乙醇胺0.15-0.5%;B组分:蜂蜜提取物0.5-5%,LS9088:1-3%,黄柏提取物0.5-2.0%,水解印榕仙人掌花提取物1-3%,穗花牡荆提取物0.5-1.5%,辛酸丙基庚酯2-6%;C组分:霍霍巴油2-10%,聚二甲基硅氧烷2-5%;D组分:防腐剂0.2-1%,香精0.1-0.3%。
以上所述很多祛痘产品其主要成分是中草药植物,运用清爽控油预防痘痘产生,慢慢调理肌肤的内部环境最终达到祛痘的目的。传统的消斑润肤的单一作用,油溶性软膏易污染衣物,涂展性差的缺点。清洁是护肤的第一步,也是抗痘的第一步,如果从第一步就忽略或者选错洁面产品,出油、毛孔粗大、痘痘等肌肤问题只会更加严重,肌肤也会变得越来越脆弱,抗痘也会变得相对比较困难,因为毛孔的堵塞也会阻碍祛痘产品的吸收。
发明内容
本发明的目的是:一是采用纯天然中草药酸荔枝核材料制成,气味清香,且无刺激,无过敏反应,使药物能迅速渗透至肌肤内层,促进营养成分的吸收,促进肌肤新陈代谢;二是克服现有的制备方法存在的其提取率低,不能将某些高沸点药物的成分全部提取使用,低挥发度药物的挥发性成分容易逸散,药材的有效成分损失大的不足而提供一种中药消炎拔痘美容霜及其制备方法。
本发明的技术方案为:
本发明根据中医学理论用中药清除皮层及体内游离脂肪酸,抑制或杀灭丙酸痤疮棒状杆菌活性。选用能够清热解毒,消痈散结,凉血养血,收敛止血,消肿生肌,生肌止痛,抗菌和杀灭丙酸痤疮棒状杆菌活性,清除游离脂肪酸,改善人体微循环,促进皮肤新陈代谢,使肌肤恢复活力中药材的家传秘方,同时添加纯天然抗氧化成分,是从酸荔枝核中提取的天然抗氧化成分,制备具有消炎拔痘美容霜。
本发明采用的中药物药理为:
1、酸荔枝核:酸荔枝核(Acid litchi),酸荔枝核为无患子科植物酸荔枝的干燥成熟种子,别名:荔仁、枝核、荔核、大荔核。其性味甘、微苦,性温。归肝、肾经,有补脾、益肝、养血、悦颜之功效。主要用于治疗寒疝腹痛、睾丸肿痛、胃脘痛、妇女气滞血瘀腹痛等症。
2、大风子仁:大风子仁(Semen Hydnocarpi Anthelmiticae),大风子科植物大风子的干燥种仁。别名:大枫子、麻风子、驱虫大风子。味辛,性热,有毒。归肝、脾、肾经。具有攻毒杀虫,祛风燥湿功效。用于疥癣、酒渣鼻、粉刺、黧黑斑、雀斑、汗斑、白癜风、白庀、体气、瘢痕疙瘩、荨麻疹、手足皲裂、神经性皮炎。
3、核桃仁:核桃仁(Juglans regial)为胡桃科植物胡桃的种子,别名:胡桃仁、胡桃肉、核桃。味甘,性温、气热、皮濇、肉润。归肺、肾、大肠经。具有温补肺肾,定喘润肠功效。用于腰膝酸软、阳痿遗精、虚寒喘嗽、大便秘结。
4、蓖麻子:蓖麻子(Semen Ricini)为大戟科植物蓖麻的种子,别名:萆麻子、蓖麻仁、大麻子、红大麻子。性平,味甘、辛。归大肠、肺经。具有泻下通滞,消肿拔毒功效。用于大便燥结,痈疽肿毒,喉痹,瘰疬,烫伤,水肿胀满;口眼歪斜,跌打损伤。
5、樟脑:樟脑(Cinnamomum camphora (L.)Presl.)别名:韶脑、潮脑、脑子、油脑、树脑。味辛,性热,有小毒。归心经;脾经。功能:通关窍、利滞气、辟秽浊、杀虫止痒、消肿止痛。主治:热病神昏、中恶猝倒、痧胀吐泻腹痛、寒湿脚气、疥疮顽癣、秃疮、冻疮、臁疮、水火烫伤、跌打伤痛、牙痛、风火赤眼。
6、松香:松香(Colophonium)别名:松脂、松膏、松肪、松胶香、白松香、松胶、黄香、松脂香。味苦、甘,性温。归肝、脾经。功效:祛风、燥湿、排脓、拔毒、生肌、止痛。主治:痈疽、疔毒、痔痿、恶疮、疥癣、白秃、金疮、扭伤、风湿痹痛、疠风瘙痒。
7、蜂蜡:蜂蜡(Apis cerana Fabr)别名:蜜蜡、蜡、蜜跖、黄蜡、白蜡、黄占。味甘、淡,性平。归脾、胃、大肠经。功效:解毒、生肌、止痢、止血、定痛。主治:痈疽发背、溃疡为敛、急心痛、下痢脓血、久泻不止、胎动下血、遗精、带下。
本发明是这样实现的:
一种中药消炎拔痘美容霜,由以下原料组分和重量份数制成:酸荔枝核3-3.5份,大风子仁0.6份,核桃仁0.6份,蓖麻子0.5-0.6份,樟脑0.6份,松香0.0375份,蜂蜡0.3份,硬脂酸0.45份,甘油0.37-0.38份,三乙醇胺0.075份,尼泊金甲酯0.0037-0.0039份,尼泊金乙酯0.0037-0.0039份,自乳化单甘酯0.0375份,吐温-80 0.037-0.038份,去离子水加至7.5-8份。
以上所述的中药消炎拔痘美容霜,由以下原料组分和重量份数制成:酸荔枝核3.3份,大风子仁0.6份,核桃仁0.6份,蓖麻子0.6份,樟脑0.6份,松香0.0375份,蜂蜡0.3份,硬脂酸0.45份,甘油0.375份,三乙醇胺0.075份,尼泊金甲酯0.00375份,尼泊金乙酯0.00375份,自乳化单甘酯0.0375份,吐温-80 0.0375份,去离子水加至7.5份。
以上所述的中药消炎拔痘美容霜的制备方法,包括中药有效成分提取、脱色和制备中药消炎拔痘美容霜,其工艺步骤如下:
(1)粉碎:将酸荔枝核中药用粉碎机粉碎成过40目筛的中药粉备用;
(2)榨油:将大风子仁、核桃仁、蓖麻子按常规榨油方法榨油,取各所得的油脂备用;
(3)醇提:将酸荔枝核中药粗粉用15-20倍量50%的乙醇水溶液浸泡15-25分钟,再用微波法从中药粗粉中提取活性成分,一次过滤,一次减压浓缩得到浸膏,回收乙醇;然后用水饱和的正丁醇溶解浸膏,二次过滤,二次减压浓缩,制成清膏,回收正丁醇;
(4)脱色:将樟脑、松香、蜂蜡、(3)步的清膏、(2)步的油脂用2-3倍量70%的乙醇水溶液加热40℃溶解、稀释,再加入活性炭搅拌脱色,每次加入的质量比为1:0.5,分三次脱色,可得基本澄清的油,再分离出油,三次过滤,三次减压浓缩,得到比重1.10-1.20膏态中药有效成分,分别回收活性炭和乙醇;
(5)乳化:将油和吐温-80研磨均匀,再加入硬脂酸、自乳化单甘酯置90℃水浴熔融并保温25min不断搅拌均匀的油相;另将甘油、三乙醇胺、去离子水置90℃水浴保温25min不断搅拌均匀的水相;再将尼泊金甲、乙酯用适量乙醇溶解加入水相中,在75℃搅拌下将水相加入至油相中乳化,75℃保温并搅拌20min不断搅拌至室温可得,将其乳化剂基质和中药提取物采用常规方法乳化,均质得到中药消炎拔痘美容霜。
以上所述的微波法控制时间90秒,微波功率210-500瓦。
本发明的优点和积极效果:
1、本发明产品采用中草药为主原料,克服了传统的消斑润肤的单一作用,油溶性软膏易污染衣物,涂展性差的缺点,而且还有抗衰老的作用。衰老是自由基对细胞成分的有害攻击所造成的,传统的化学合成抗氧化剂具有一定的副作用和致癌性,本品的酸荔枝核提取物表现出较强的清除自由基能力,是一种较好的天然抗氧化剂和自由基清除剂,在祛除斑点同时,对抗自由基,并促进胶原蛋白生成,能够有效地延缓衰老。并且外观良好,色泽自然,稠度适中,耐热耐寒,稳定性佳,质地细腻,易于涂展,不油腻并易于洗除,对皮肤无刺激性,释放性能好,药物的出膏率高且对皮肤的穿透性能好。增加皮肤弹性,减轻色素沉着的作用。
2、本发明采用有效的药物制剂使药物聚集到皮肤活性部位达到起效浓度是本品研究的关键。本制备采用了微波提取酸荔枝核中黄酮类化合物的最佳提取工艺的方法,微波提取物比热侵提取物、回流提取物对油脂抗氧化作用都强,提取率高,能够有效提取中药中抗氧化成分,提高中药的功能,同时利用最优化工艺进行乳化剂基质制备,两者相联合达到良好的祛斑润肤的作用,并节约有限而价高中药资源。
3、本方法优化工艺条件,在实际生产中应用,简单、易行、重现性好,具有较好的经济效益和社会效益。
具体实施方式
以下结合实施例对本发明作进一步详细描述,所列实施例仅在于说明本发明而绝不限于本发明。
一、产品制备实施例
实施例1
(一)中药组方:
酸荔枝核3.3公斤,大风子仁0.6公斤,核桃仁0.6公斤,蓖麻子0.6公斤,樟脑0.6公斤,松香0.0375公斤, 蜂蜡0.3公斤,硬脂酸0.45公斤,甘油0.375公斤,三乙醇胺0.075公斤,尼泊金甲、乙酯各0.00375公斤,自乳化单甘酯0.0375公斤,吐温-80 0.0375公斤,去离子水加至7.5公斤。
(二)制备方法:
将酸荔枝核用粉碎机粉碎成40目中药粗粉,将粗粉用50%乙醇进行微波提取, 物料比为1:20,浸泡15分钟,微波功率212.1瓦,提取时间为90秒,得到的滤液趁热过滤,除去滤渣并将滤液置温度70℃进行真空浓缩得到中药提取物。一次过滤,一次减压浓缩得到比重1.10浸膏,回收乙醇;然后用水饱和的正丁醇溶解浸膏,二次过滤,二次减压浓缩,制成清膏,回收正丁醇。将樟脑、松香、制得的清膏,同时将大风子仁、核桃仁、蓖麻子榨的油脂混合在一起,用2倍量70%的乙醇水溶液加热40℃溶解、稀释,再加入活性炭搅拌脱色,每次加入的质量比为1:0.5,分三次脱色,可得基本澄清的油。再分离出油,三次过滤,三次减压浓缩,得到比重1.20膏态的药油。蜂蜡加热溶化,滤过,加上以上制得的膏态的药油及吐温-80研磨均匀分散后加入组方量的樟脑、松香、蜂蜡、硬脂酸、自乳化单甘酯置90℃水浴熔融并保温25min不断搅拌均匀的油相。另将甘油、三乙醇胺、去离子水置90℃水浴保温25min不断搅拌均匀的水相。尼泊金甲、乙酯用适量乙醇溶解加入水相中。75℃搅拌下将水相加入至油相中乳化,75℃保温并搅拌20min不断搅拌至室温可得。将其乳化剂基质和中药提取物采用制备方法乳化,均质,得到天然祛斑润肤膏。
实施例2
(一)中药组方:
酸荔枝核3.5公斤,大风子仁0.6公斤,核桃仁0.6公斤,蓖麻子0.6公斤,樟脑0.6公斤,松香0.0375公斤, 蜂蜡0.3公斤,硬脂酸0.45公斤,甘油0.375公斤,三乙醇胺0.075公斤,尼泊金甲、乙酯各0.00375公斤,自乳化单甘酯0.0375公斤,吐温-80 0.0375公斤,去离子水加至7.5公斤。
(二)制备方法:
将酸荔枝核用粉碎机粉碎成40目中药粗粉,将粗粉用50%乙醇进行微波提取, 物料比为1:15,浸泡20分钟,微波功率212.1瓦,提取时间为90秒,得到的滤液趁热过滤,除去滤渣并将滤液置温度70℃进行真空浓缩得到中药提取物,一次过滤,一次减压浓缩得到比重1.15浸膏,回收乙醇;然后用水饱和的正丁醇溶解浸膏,二次过滤,二次减压浓缩,制成清膏,回收正丁醇。将樟脑、松香、蜂蜡、制得的清膏,同时将大风子仁、核桃仁、蓖麻子榨的油脂混合在一起,用3倍量70%的乙醇水溶液加热40℃溶解、稀释,再加入活性炭搅拌脱色,每次加入的质量比为1:0.5,分三次脱色,可得基本澄清的油。再分离出油,三次过滤,三次减压浓缩,得到比重1.15膏态的药油。蜂蜡加热溶化,滤过,加上以上制得的膏态的药油及吐温-80研磨均匀分散后加入组方量的樟脑、松香、蜂蜡、硬脂酸、自乳化单甘酯置90℃水浴熔融并保温25min不断搅拌均匀的油相。另将甘油、三乙醇胺、去离子水置90℃水浴保温25min不断搅拌均匀的水相。尼泊金甲、乙酯用适量乙醇溶解加入水相中。75℃搅拌下将水相加入至油相中乳化,75℃保温并搅拌20min不断搅拌至室温,均质,得到天然祛斑润肤膏。
实施例3
(一)中药组方:
酸荔枝核3公斤,大风子仁0.5公斤,核桃仁0.6公斤,蓖麻子0.6公斤,樟脑0.6公斤,松香0.0375公斤, 蜂蜡0.3公斤,硬脂酸0.45公斤,甘油0.38公斤,三乙醇胺0.075公斤,尼泊金甲、乙酯各0.0037公斤,自乳化单甘酯0.039公斤,吐温-80 0.038公斤,去离子水加至8公斤。
(二)制备方法:
将酸荔枝核用粉碎机粉碎成40目中药粗粉,将粗粉用50%乙醇进行微波提取,物料比为1∶15,浸泡25分钟,微波功率212.1瓦,提取时间为90秒,得到的滤液趁热过滤,除去滤渣并将滤液置温度70℃进行真空浓缩得到中药提取物,一次过滤,一次减压浓缩得到比重1.20浸膏,回收乙醇;然后用水饱和的正丁醇溶解浸膏,二次过滤,二次减压浓缩,制成清膏,回收正丁醇。将樟脑、松香、制得的清膏,同时将大风子仁、核桃仁、蓖麻子榨的油脂混合在一起,用2.5倍量70%的乙醇水溶液加热40℃溶解、稀释,再加入活性炭搅拌脱色,每次加入的质量比为1:0.5,分三次脱色,可得基本澄清的油。再分离出油,三次过滤,三次减压浓缩,得到比重1.20膏态的药油。蜂蜡加热溶化,滤过,加上以上制得的膏态的药油及吐温-80研磨均匀分散后加入组方量的樟脑、松香、蜂蜡、硬脂酸、自乳化单甘酯置90℃水浴熔融并保温25min不断搅拌均匀的油相。另将甘油、三乙醇胺、去离子水置90℃水浴保温25min不断搅拌均匀的水相。尼泊金甲、乙酯用适量乙醇溶解加入水相中。75℃搅拌下将水相加入至油相中乳化,75℃保温并搅拌20min不断搅拌至室温,可得均质,得到天然祛斑润肤膏。
二、应用实例
1、王X X,女性,年龄:26,职业:财务公司文员。皮肤症状:痘痘、红肿、有脓包,使用本产品前:痘痘密集、有红肿。使用本实施例1产品,采取每天早、中、晚三次在脸上涂抹,特别针对痘痘涂抹,连同红肿部位反复多次擦试增加霜量,5天疼痛感减轻,红肿的痘痘表面干瘪;20天痘痘得到了初步抑制,慢慢减少,痘痘表皮结茄脱落,痘印逐渐变淡;坚持用45天痘痘得到抑制,痘印大部分消失,皮肤渐渐平滑白皙,红润光泽。
2、韦X X,男性,年龄:26,职业:企业管理。 皮肤症状:毛孔粗大,油脂旺盛,脸庞有大面积痘痘,鼻子两侧长黑头,使用前,满面油光,带有红肿疼痛。使用本实施例2产品,每天早晚各涂抹一次30分钟,三天后红肿疼痛感觉减轻;八天后痘痘、粉刺开始萎缩,面部油性降低;14天黑头脱落,红肿消失疼痛感完全没有;21天后油光消除,痘印淡化;连续用49天皮肤毛孔细腻平滑,痘印无痕、油光消失,黑头、痘痘再无复发,痘痘得到了有效地抑制。
3、陆X X:女性,年龄29岁,职业:中学老师。皮肤症状:面部皮肤干燥、无光滑,无弹性,有青春痘和黄斑。每天晚上温水清洗面部再擦本实施例2产品,开始一周无明显变化;两周后面部皮肤得到改善,肤色变红润,恢复弹性,青春痘生长数量得到抑制;使用四周天面部皮肤活力增强,皮肤干燥感得到改善,黄斑减少;坚持使用十周后面部皮肤变润滑细嫩,黄斑和青春痘消失,皮肤红润有光泽。
4、黄X X,男性,年龄:23,职业:学生。皮肤症状:毛孔较大,油脂旺盛,皮肤为油性,鼻子两侧长黑头,使用本产品前,满面油光,带有红肿疼痛。使用本实施例1产品,每天早晚各涂抹一次15分钟,六天后疼痛感觉减轻比较明显;一周后痘痘、粉刺开始萎缩,面部油性降低;14天黑头脱落,红肿消失疼痛感完全没有;三周后油光消除,痘印淡化;连续用八周皮肤毛孔细腻平滑,痘印无痕、油光消失,黑头、痘痘再无复发,痘痘得到了有效地抑制。
Claims (4)
1.一种中药消炎拔痘美容霜,其特征在于:由以下原料组分和重量份数制成:酸荔枝核3-3.5份,大风子仁0.6份,核桃仁0.6份,蓖麻子0.5-0.6份,樟脑0.6份,松香0.0375份,蜂蜡0.3份,硬脂酸0.45份,甘油0.37-0.38份,三乙醇胺0.075份,尼泊金甲酯0.0037-0.0039份,尼泊金乙酯0.0037-0.0039份,自乳化单甘酯0.0375份,吐温-80 0.037-0.038份,去离子水加至7.5-8份。
2.根据权利要求1所述的一种中药消炎拔痘美容霜,其特征在于:所述的中药消炎拔痘美容霜,由以下原料组分和重量份数制成:酸荔枝核3.3份,大风子仁0.6份,核桃仁0.6份,蓖麻子0.6份,樟脑0.6份,松香0.0375份,蜂蜡0.3份,硬脂酸0.45份,甘油0.375份,三乙醇胺0.075份,尼泊金甲酯0.00375份,尼泊金乙酯0.00375份,自乳化单甘酯0.0375份,吐温-80 0.0375份,去离子水加至7.5份。
3.根据权利要求1或2所述的一种中药消炎拔痘美容霜的制备方法,其特征在于:包括中药有效成分提取、脱色和制备中药消炎拔痘美容霜,其工艺步骤如下:
(1)粉碎:将酸荔枝核中药用粉碎机粉碎成过40目筛的中药粉备用;
(2)榨油:将大风子仁、核桃仁、蓖麻子按常规榨油方法榨油,取各所得的油脂备用;
(3)醇提:将酸荔枝核中药粗粉用15-20倍量50%的乙醇水溶液浸泡15-25分钟,再用微波法从中药粗粉中提取活性成分,一次过滤,一次减压浓缩得到浸膏,回收乙醇;然后用水饱和的正丁醇溶解浸膏,二次过滤,二次减压浓缩,制成清膏,回收正丁醇;
(4)脱色:将樟脑、松香、蜂蜡、(3)步的清膏、(2)步的油脂用2-3倍量70%的乙醇水溶液加热40℃溶解、稀释,再加入活性炭搅拌脱色,每次加入的质量比为1:0.5,分三次脱色,可得基本澄清的油,再分离出油,三次过滤,三次减压浓缩,得到比重1.10-1.20膏态中药有效成分,分别回收活性炭和乙醇;
(5)乳化:将油和吐温-80研磨均匀,再加入硬脂酸、自乳化单甘酯置90℃水浴熔融并保温25min不断搅拌均匀的油相;另将甘油、三乙醇胺、去离子水置90℃水浴保温25min不断搅拌均匀的水相;再将尼泊金甲、乙酯用适量乙醇溶解加入水相中,在75℃搅拌下将水相加入至油相中乳化,75℃保温并搅拌20min不断搅拌至室温可得,将其乳化剂基质和中药提取物采用常规方法乳化,均质得到中药消炎拔痘美容霜。
4.根据权利要求3所述的一种中药消炎拔痘美容霜的制备方法,其特征在于:所述的微波法控制时间90秒,微波功率210-500瓦。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410292438.1A CN104095783A (zh) | 2014-06-26 | 2014-06-26 | 一种中药消炎拔痘美容霜及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410292438.1A CN104095783A (zh) | 2014-06-26 | 2014-06-26 | 一种中药消炎拔痘美容霜及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104095783A true CN104095783A (zh) | 2014-10-15 |
Family
ID=51664582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410292438.1A Pending CN104095783A (zh) | 2014-06-26 | 2014-06-26 | 一种中药消炎拔痘美容霜及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104095783A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105125469A (zh) * | 2015-10-09 | 2015-12-09 | 吴优 | 一种多效祛痘护肤品及其制备方法 |
CN105919499A (zh) * | 2015-06-08 | 2016-09-07 | 庄可军 | 一种具有活性炭填充层的清洁座便套垫 |
CN105942915A (zh) * | 2015-06-08 | 2016-09-21 | 庄可军 | 一种马桶用封闭式防蚊坐垫及装置该护垫的抽水马桶 |
CN105996878A (zh) * | 2015-06-08 | 2016-10-12 | 庄可军 | 一种多功能家居用保健纸抽 |
CN106983832A (zh) * | 2017-06-06 | 2017-07-28 | 合肥华盖生物科技有限公司 | 一种皮肤用消毒剂及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012033422A1 (en) * | 2010-09-06 | 2012-03-15 | Aleksandar Pavlov | Medical cosmetic herbal composition on the basis of herbal mixture and the procedure for its obtention |
CN102813696A (zh) * | 2012-08-27 | 2012-12-12 | 广西金海堂药业有限责任公司 | 一种治疗真菌类皮肤病的中药制剂及其制备方法 |
-
2014
- 2014-06-26 CN CN201410292438.1A patent/CN104095783A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012033422A1 (en) * | 2010-09-06 | 2012-03-15 | Aleksandar Pavlov | Medical cosmetic herbal composition on the basis of herbal mixture and the procedure for its obtention |
CN102813696A (zh) * | 2012-08-27 | 2012-12-12 | 广西金海堂药业有限责任公司 | 一种治疗真菌类皮肤病的中药制剂及其制备方法 |
Non-Patent Citations (11)
Title |
---|
中华人民共和国卫生部: "《化妆品卫生规范》", 31 January 2007 * |
伯杰龙等: "《生物炼制产品与技术》", 31 January 2013, 上海科学技术出版社 * |
刘树民: "《中药药物性肝损害》", 30 September 2007, 中国中医药出版社 * |
汤建萍: "中药荔枝核活性成分的分离制备新工艺及其药效活性研究", 《中国博士学位论文全文数据库工程科技I辑》 * |
王建等: "《中药学专业知识.1》", 31 March 2014, 中国医药科技出版社 * |
胡元亮: "《中兽医学》", 31 December 2006, 中国农业出版社 * |
胡昌江等: "《中药炮制与临床应用》", 30 June 1992, 四川科学技术出版社 * |
董银卯等: "《本草药妆品》", 30 June 2010, 化学工业出版社 * |
邱汉琛等: "对广西壮药酸荔枝叶皮核化学成分预试验", 《广州化学》 * |
阎世翔: "《化妆品科学(下)》", 31 October 1998, 科学技术文献出版社 * |
陆永旺等: "酸荔枝核黄酮体外抗氧化作用的研究", 《中国酿造》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105919499A (zh) * | 2015-06-08 | 2016-09-07 | 庄可军 | 一种具有活性炭填充层的清洁座便套垫 |
CN105942915A (zh) * | 2015-06-08 | 2016-09-21 | 庄可军 | 一种马桶用封闭式防蚊坐垫及装置该护垫的抽水马桶 |
CN105996878A (zh) * | 2015-06-08 | 2016-10-12 | 庄可军 | 一种多功能家居用保健纸抽 |
CN105996878B (zh) * | 2015-06-08 | 2018-07-31 | 庄可军 | 一种多功能家居用保健纸抽 |
CN105919499B (zh) * | 2015-06-08 | 2018-07-31 | 庄可军 | 一种具有活性炭填充层的清洁座便套垫 |
CN105942915B (zh) * | 2015-06-08 | 2018-08-03 | 庄可军 | 一种马桶用封闭式防蚊坐垫及装置该坐垫的抽水马桶 |
CN105125469A (zh) * | 2015-10-09 | 2015-12-09 | 吴优 | 一种多效祛痘护肤品及其制备方法 |
CN105125469B (zh) * | 2015-10-09 | 2018-02-13 | 佛山市万盈化妆品有限公司 | 一种多效祛痘护肤品及其制备方法 |
CN106983832A (zh) * | 2017-06-06 | 2017-07-28 | 合肥华盖生物科技有限公司 | 一种皮肤用消毒剂及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103571657B (zh) | 一种除痘的天然皂及其制备方法 | |
CN102342993B (zh) | 一种皮肤抗敏修复外用制剂 | |
CN103479775B (zh) | 一种刮痧油及其制备方法 | |
US9554985B2 (en) | Agent for promoting hair growth and method for preparing same | |
CN105779175A (zh) | 一种具有祛痘功能的天然手工皂及其制备方法 | |
KR20010000396A (ko) | 미백 화장료 | |
CN104095783A (zh) | 一种中药消炎拔痘美容霜及其制备方法 | |
CN105125466A (zh) | 一种祛斑晚霜及其制备方法 | |
CN109248194A (zh) | 一种治疗脚气的精油组合物及其制剂 | |
KR102049208B1 (ko) | 여드름 완화 및 피지 분비 억제용 화장료 조성물 | |
CN114146014B (zh) | 一种复方烟酸薄荷酯植物多糖乳膏及其制备方法 | |
CN102670479B (zh) | 中药消炎拔痘美容霜及其制备方法 | |
CN106344458A (zh) | 一种含人参和鹿茸的美白霜 | |
CN105581915A (zh) | 一种中药成分的皮脂膜修复型卸妆膏及其制备方法 | |
CN105213279A (zh) | 一种消除萎缩纹的身体乳及其制备方法 | |
CN112891504A (zh) | 一种以生姜药渣为基材的四季护肤防疫生姜膏及制备方法 | |
CN106667852A (zh) | 一种中药祛痘霜及其制备方法 | |
KR20210088068A (ko) | 천연오일 성분이 함유된 탈모방지 기능성 비누 | |
KR101183893B1 (ko) | 아토피 피부염 개선능을 갖는 화장료 조성물 및 이의 사용방법 | |
CN106236650B (zh) | 一种祛痘控油乳膏剂及其制备方法 | |
CN109010520A (zh) | 一种治疗暗疮的药膏及其制备方法 | |
CN111040896A (zh) | 一种抗菌消炎美肤手工皂 | |
CN101229258B (zh) | 抗过敏消炎膏 | |
CN106727051A (zh) | 一种中药祛痘精华及其制备方法 | |
CN105687051A (zh) | 具有除粉刺效果的沐浴盐及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141015 |